Evidence map›Paper›PMID 36453894›Full record

ArticleMicrobiology spectrum2022

Klebsiella Species and Enterobacter cloacae Isolates Harboring

Samiratu Mahazu, Isaac Prah, Yusuke Ota, Takaya Hayashi, Yoko Nukui, Masato Suzuki, Yoshihiko Hoshino, Yukihiro Akeda, Toshihiko Suzuki, Tomoko Ishino and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Samiratu MahazuDepartment of Molecular Microbiology, Tokyo Medical and Dental University, Tokyo, Japan.
Isaac PrahDepartment of Molecular Microbiology, Tokyo Medical and Dental University, Tokyo, Japan.
Yusuke OtaDepartment of Molecular Microbiology, Tokyo Medical and Dental University, Tokyo, Japan.
Takaya HayashiDepartment of Molecular Virology, Tokyo Medical and Dental University, Tokyo, Japan.
Yoko NukuiDepartment of Infection Control and Prevention, Tokyo Medical and Dental University Hospital, Tokyo, Japan.
Masato SuzukiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yoshihiko HoshinoDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yukihiro AkedaDepartment of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.
Toshihiko SuzukiDepartment of Bacterial Pathogenesis, Tokyo Medical and Dental University, Tokyo, Japan.
Tomoko IshinoDepartment of Parasitology and Tropical Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Anthony AblordeyDepartment of Bacteriology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
Ryoichi SaitoDepartment of Molecular Microbiology, Tokyo Medical and Dental University, Tokyo, Japan.ORCID 0000-0003-3398-8572
Tokyo Medical and Dental University · JPNational Institute of Infectious Diseases · JPKyoto Prefectural University of Medicine · JPUniversity of Ghana · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IncX3 and IncL plasmids have been named as catalysts advancing dissemination of

Indexed as

Enterobacter cloacaeKlebsiella pneumoniaeAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsDrug Resistance, BacterialGhanaHumansKlebsiella InfectionsMicrobial Sensitivity TestsPlasmidsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsfitness costIncLIncX3oxacillinase-181 (OXA-181)oxacillinase-48 (OXA-48)plasmid stability

Identifiers

PMID36453894
PMCPMC9769605
OpenAlexW4310524732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.